Skip to main content
SpringerLink
Log in

Imatinib/nilotinib

Multisystem toxicities: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gurianova MA, et al. [Successful use of long-term follow-up in patients with chronic myeloid leukemia with a deep molecular response at reduced doses of 2nd generation tyrosine kinase inhibitors: clinical cases and literature review]. Terapevticheskii Arkhiv 92: 90-94, No. 7, Sep 2020. Available from: URL: http://doi.org/10.26442/00403660.2020.07.000789 [Russian; summarised from a translation]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Imatinib/nilotinib. Reactions Weekly 1842, 207 (2021). https://doi.org/10.1007/s40278-021-90943-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-90943-3

Search

Navigation